Reikvam H - Search Results

1

The Rac1-inhibitor EHop-016 attenuates AML cell migration and enhances the efficacy of daunorubicin in MOLM-13 transplanted zebrafish larvae.

Hemsing AL, Førde JL, Reikvam H, Herfindal L. Hemsing AL, et al. Among authors: reikvam h. Transl Oncol. 2024 Feb;40:101876. doi: 10.1016/j.tranon.2024.101876. Epub 2024 Jan 6. Transl Oncol. 2024. PMID: 38185059 Free PMC article.

2

Trisomy 8 in acute myeloid leukemia.

Hemsing AL, Hovland R, Tsykunova G, Reikvam H. Hemsing AL, et al. Among authors: reikvam h. Expert Rev Hematol. 2019 Nov;12(11):947-958. doi: 10.1080/17474086.2019.1657400. Epub 2019 Sep 26. Expert Rev Hematol. 2019. PMID: 31422708 Review.

3

Mondor's disease after extensive training with Nordic walking.

Hemsing AL, Reikvam H. Hemsing AL, et al. Among authors: reikvam h. Oxf Med Case Reports. 2019 Aug 28;2019(8):omz075. doi: 10.1093/omcr/omz075. eCollection 2019 Aug. Oxf Med Case Reports. 2019. PMID: 31772743 Free PMC article.

4

Severe nephritis as initial sign of Waldenström's macroglobulinemia.

Knoop T, Larsen KK, Leh F, Hemsing AL, Teigen IA, Reikvam H. Knoop T, et al. Among authors: reikvam h. Clin Pract. 2019 Dec 19;9(4):1184. doi: 10.4081/cp.2019.1184. eCollection 2019 Nov 5. Clin Pract. 2019. PMID: 31929868 Free PMC article.

5

Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment.

Hansen BA, Wendelbo Ø, Bruserud Ø, Hemsing AL, Mosevoll KA, Reikvam H. Hansen BA, et al. Among authors: reikvam h. Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020009. doi: 10.4084/MJHID.2020.009. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 31934319 Free PMC article. Review.

6

Therapy for acute myelogenous leukemia revisited: moving away from a one-size-fits-all approach.

Reikvam H, Hemsing AL, Smith C. Reikvam H, et al. Expert Rev Anticancer Ther. 2021 Jan;21(1):5-8. doi: 10.1080/14737140.2021.1838901. Epub 2020 Oct 25. Expert Rev Anticancer Ther. 2021. PMID: 33059507 No abstract available.

7

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation.

Hemsing AL, Gjertsen BT, Spetalen S, Helgeland L, Reikvam H. Hemsing AL, et al. Among authors: reikvam h. SAGE Open Med Case Rep. 2021 Jan 22;9:2050313X20988413. doi: 10.1177/2050313X20988413. eCollection 2021. SAGE Open Med Case Rep. 2021. PMID: 33628448 Free PMC article.

8

Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia.

Reikvam H, Hemsing AL, Hernandez-Valladares M, Birkeland E. Reikvam H, et al. Expert Rev Proteomics. 2022 Feb;19(2):73-76. doi: 10.1080/14789450.2022.2067530. Epub 2022 Apr 22. Expert Rev Proteomics. 2022. PMID: 35436165 No abstract available.

9

MicroRNA serum profiles and chronic graft-versus-host disease.

Reikvam H, Vo AK, Johansen S, Hemsing AL, Solheim MH, Mosevoll KA, Tvedt THA, Hatfield KJ. Reikvam H, et al. Blood Adv. 2022 Sep 27;6(18):5295-5306. doi: 10.1182/bloodadvances.2021005930. Blood Adv. 2022. PMID: 35443023 Free PMC article.

10

NPM1-Mutated Patient-Derived AML Cells Are More Vulnerable to Rac1 Inhibition.

Hemsing AL, Rye KP, Hatfield KJ, Reikvam H. Hemsing AL, et al. Among authors: reikvam h. Biomedicines. 2022 Aug 4;10(8):1881. doi: 10.3390/biomedicines10081881. Biomedicines. 2022. PMID: 36009428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page